These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18442866)

  • 21. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms.
    Guse C; Koennings S; Kreye F; Siepmann F; Goepferich A; Siepmann J
    Int J Pharm; 2006 May; 314(2):137-44. PubMed ID: 16503388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: model validation.
    Miller JM; Dahan A
    Int J Pharm; 2012 Jul; 430(1-2):388-91. PubMed ID: 22465550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mathematical modeling of drug release from lipid dosage forms.
    Siepmann J; Siepmann F
    Int J Pharm; 2011 Oct; 418(1):42-53. PubMed ID: 21802501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mathematical model for interpreting in vitro rhGH release from laminar implants.
    Santoveña A; García JT; Oliva A; Llabrés M; Fariña JB
    Int J Pharm; 2006 Feb; 309(1-2):38-43. PubMed ID: 16376037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
    Xu X; Chen X; Ma P; Wang X; Jing X
    Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-solubilization of poorly soluble drugs by micellization and complexation.
    Rao VM; Nerurkar M; Pinnamaneni S; Rinaldi F; Raghavan K
    Int J Pharm; 2006 Aug; 319(1-2):98-106. PubMed ID: 16765542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical kinetic model of propafenone release from Hot Air Coating microparticles.
    Segale L; Albertini B; Giovannelli L; Pattarino F
    Int J Pharm; 2008 Apr; 353(1-2):124-30. PubMed ID: 18162344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug release mechanisms of cast lipid implants.
    Kreye F; Siepmann F; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):394-400. PubMed ID: 21352913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants.
    Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU
    Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aqueous HPMCAS coatings: effects of formulation and processing parameters on drug release and mass transport mechanisms.
    Siepmann F; Siepmann J; Walther M; MacRae R; Bodmeier R
    Eur J Pharm Biopharm; 2006 Jul; 63(3):262-9. PubMed ID: 16621484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
    Campbell K; Craig DQ; McNally T
    Int J Pharm; 2008 Nov; 363(1-2):126-31. PubMed ID: 18657600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
    Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
    Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs acting as plasticizers in polymeric systems: a quantitative treatment.
    Siepmann F; Le Brun V; Siepmann J
    J Control Release; 2006 Oct; 115(3):298-306. PubMed ID: 17045358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability.
    Schoenhammer K; Petersen H; Guethlein F; Goepferich A
    Int J Pharm; 2009 Apr; 371(1-2):33-9. PubMed ID: 19135512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictability of drug release from cochlear implants.
    Krenzlin S; Vincent C; Munzke L; Gnansia D; Siepmann J; Siepmann F
    J Control Release; 2012 Apr; 159(1):60-8. PubMed ID: 22233971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.